95 related articles for article (PubMed ID: 38187605)
1. Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axis.
Bannoura SF; Aboukameel A; Khan HY; Uddin MH; Jang H; Beal E; Thangasamy A; Kim S; Wagner KU; Mohammad R; Al-Hallak MN; Pasche BC; Azmi AS
bioRxiv; 2023 Dec; ():. PubMed ID: 38187605
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model.
Uddin MH; Al-Hallak MN; Khan HY; Aboukameel A; Li Y; Bannoura SF; Dyson G; Kim S; Mzannar Y; Azar I; Odisho T; Mohamed A; Landesman Y; Kim S; Beydoun R; Mohammad RM; Philip PA; Shields AF; Azmi AS
Clin Transl Med; 2023 Dec; 13(12):e1513. PubMed ID: 38131168
[TBL] [Abstract][Full Text] [Related]
3. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
Jiang SH; Li J; Dong FY; Yang JY; Liu DJ; Yang XM; Wang YH; Yang MW; Fu XL; Zhang XX; Li Q; Pang XF; Huo YM; Li J; Zhang JF; Lee HY; Lee SJ; Qin WX; Gu JR; Sun YW; Zhang ZG
Gastroenterology; 2017 Jul; 153(1):277-291.e19. PubMed ID: 28315323
[TBL] [Abstract][Full Text] [Related]
4. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptor potentiates macropinocytosis through CDC42 in pancreatic ductal adenocarcinoma.
Liao YN; Gai YZ; Qian LH; Pan H; Zhang YF; Li P; Guo Y; Li SX; Nie HZ
Oncogenesis; 2024 Feb; 13(1):10. PubMed ID: 38424455
[TBL] [Abstract][Full Text] [Related]
6. Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
Nagathihalli NS; Castellanos JA; Lamichhane P; Messaggio F; Shi C; Dai X; Rai P; Chen X; VanSaun MN; Merchant NB
Cancer Res; 2018 Nov; 78(21):6235-6246. PubMed ID: 30154150
[TBL] [Abstract][Full Text] [Related]
7. Moderate alcohol intake promotes pancreatic ductal adenocarcinoma development in mice expressing oncogenic Kras.
Asahina K; Balog S; Hwang E; Moon E; Wan E; Skrypek K; Chen Y; Fernandez J; Romo J; Yang Q; Lai K; French SW; Tsukamoto H
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G265-G276. PubMed ID: 31760766
[No Abstract] [Full Text] [Related]
8. Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC.
Cao XY; Zhang XX; Yang MW; Hu LP; Jiang SH; Tian GA; Zhu LL; Li Q; Sun YW; Zhang ZG
Biochem Biophys Res Commun; 2018 May; 499(3):584-593. PubMed ID: 29621546
[TBL] [Abstract][Full Text] [Related]
9. CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma.
Morita T; Kodama Y; Shiokawa M; Kuriyama K; Marui S; Kuwada T; Sogabe Y; Matsumori T; Kakiuchi N; Tomono T; Mima A; Ueda T; Tsuda M; Yamauchi Y; Nishikawa Y; Sakuma Y; Ota Y; Maruno T; Uza N; Nagasawa T; Chiba T; Seno H
Cancer Res; 2020 Oct; 80(19):4058-4070. PubMed ID: 32606001
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
[TBL] [Abstract][Full Text] [Related]
11. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial Protein UQCRC1 is Oncogenic and a Potential Therapeutic Target for Pancreatic Cancer.
Wang Q; Li M; Gan Y; Jiang S; Qiao J; Zhang W; Fan Y; Shen Y; Song Y; Meng Z; Yao M; Gu J; Zhang Z; Tu H
Theranostics; 2020; 10(5):2141-2157. PubMed ID: 32089737
[No Abstract] [Full Text] [Related]
13. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
14. Vasohibin-2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma.
Iida-Norita R; Kawamura M; Suzuki Y; Hamada S; Masamune A; Furukawa T; Sato Y
Cancer Sci; 2019 Jul; 110(7):2296-2308. PubMed ID: 31074083
[TBL] [Abstract][Full Text] [Related]
15. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
[TBL] [Abstract][Full Text] [Related]
16. A ketogenic diet in combination with gemcitabine increases survival in pancreatic cancer KPC mice.
Cortez NE; Rodriguez Lanzi C; Hong BV; Xu J; Wang F; Chen S; Ramsey JJ; Pontifex MG; Müller M; Vauzour D; Vahmani P; Hwang CI; Matsukuma K; Mackenzie GG
Cancer Res Commun; 2022 Sep; 2(9):951-965. PubMed ID: 36382086
[TBL] [Abstract][Full Text] [Related]
17. Kindlin-2 enhances c-Myc translation through association with DDX3X to promote pancreatic ductal adenocarcinoma progression.
Liu C; Jiang K; Ding Y; Yang A; Cai R; Bai P; Xiong M; Fu C; Quan M; Xiong Z; Deng Y; Tian R; Wu C; Sun Y
Theranostics; 2023; 13(13):4333-4355. PubMed ID: 37649609
[No Abstract] [Full Text] [Related]
18. A low amino acid environment promotes cell macropinocytosis through the YY1-FGD6 axis in Ras-mutant pancreatic ductal adenocarcinoma.
Zhang YF; Li Q; Huang PQ; Su T; Jiang SH; Hu LP; Zhang XL; Sun Y; Pan H; Yang XM; Li J; Gai YZ; Zhu L; Yao LL; Li DX; Sun YW; Zhang ZG; Liu DJ; Zhang YL; Nie HZ
Oncogene; 2022 Feb; 41(8):1203-1215. PubMed ID: 35082383
[TBL] [Abstract][Full Text] [Related]
19. Mouse-Derived Allografts: A Complementary Model to the KPC Mice on Researching Pancreatic Cancer In Vivo.
Li J; Qian W; Qin T; Xiao Y; Cheng L; Cao J; Chen X; Ma Q; Wu Z
Comput Struct Biotechnol J; 2019; 17():498-506. PubMed ID: 31011408
[TBL] [Abstract][Full Text] [Related]
20. Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy.
Torres MP; Rachagani S; Souchek JJ; Mallya K; Johansson SL; Batra SK
PLoS One; 2013; 8(11):e80580. PubMed ID: 24278292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
